Soini Ylermi, Haapasaari Kirsi-Maria, Vaarala Markku H, Turpeenniemi-Hujanen Taina, Kärjä V, Karihtala Peeter
Department of Clinical Pathology and Forensic Medicine, Institute of Clinical Medicine, School of Medicine, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
Int J Clin Exp Pathol. 2011 Mar;4(3):267-75. Epub 2011 Mar 2.
Oxidative stress markers and peroxiredoxins are connected to cancer. A large set of urinary bladder carcinomas were studied for the expression of nitrotyrosine and 8-hydroxydeguanosine (8OHdG), two markers indicating oxidative damage. Serum and urine 8-OHdG were assessed in a subset of patients. We also analysed immunohisto-chemically the expression of nrf2, keap1, all six peroxiredoxins (prx) and thioredoxin (trx) in these tumors. 15 % of the cases showed 8OHdG and 36 % nitrotyrosine positivity. Expression of nitrotyrosine and 8OHdG associated with a poor prognosis (p=0.050, p=0.011, respectively). Peroxiredoxin positivity ranged from 39 % to 84 % lowest expression being for prx 4 and highest for prx 3. Prx 4 expression associated with a poor prognosis (p=0.025) with high grade (p=0.044) and larger tumors (p=0.023). Cytoplasmic trx positivity was seen in 91 % and nuclear in 59 % of tumors. Nuclear and cytoplasmic trx associated with each other (p<0.001), and nuclear trx associated with prx 6 (p=0.001), prx 2 (p<0.001), and prx 5 (p<0.001). 8OHdG associated with nuclear trx positivity (p=0.002), inversely with prx 1 (p=0.025) and with keap1 (p=0.020). Nuclear nrf2 was associated with nitrotyrosine (p=0.042). The results show that the amount of oxidative stress in urinary bladder tumors affects the prognosis of the patients. Of antioxidative enzymes, prx4 associated with an unfavourable prognosis. Selective inhibition of prx4 expression might then be one additional option of treatment of bladder cancer.
氧化应激标志物和过氧化物酶与癌症相关。对大量膀胱癌患者研究了硝基酪氨酸和8-羟基脱氧鸟苷(8OHdG)这两种指示氧化损伤的标志物的表达情况。在部分患者中评估了血清和尿液中的8-OHdG。我们还对这些肿瘤中核因子E2相关因子2(nrf2)、 Kelch样环氧氯丙烷相关蛋白1(keap1)、所有六种过氧化物酶(prx)和硫氧还蛋白(trx)进行了免疫组化分析。15%的病例显示8OHdG阳性,36%显示硝基酪氨酸阳性。硝基酪氨酸和8OHdG的表达与预后不良相关(分别为p = 0.050,p = 0.011)。过氧化物酶阳性率在39%至84%之间,prx 4表达最低,prx 3表达最高。Prx 4表达与预后不良相关(p = 0.025),与高级别肿瘤相关(p = 0.044),与较大肿瘤相关(p = 0.023)。91%的肿瘤可见细胞质trx阳性,59%可见细胞核trx阳性。细胞核和细胞质trx相互关联(p < 0.001),细胞核trx与prx 6相关(p = 当p<0.001时, 0.001)、与prx 2相关(p < 0.001)、与prx 5相关(p < 0.001)。8OHdG与细胞核trx阳性相关(p = 0.002),与prx 1呈负相关(p = 0.025),与keap1相关(p = 0.020)。细胞核nrf2与硝基酪氨酸相关(p = 0.042)。结果表明,膀胱肿瘤中的氧化应激量影响患者的预后。在抗氧化酶中,prx
4与不良预后相关。那么选择性抑制prx 4的表达可能是膀胱癌治疗的另一种选择。